List of insiders holdings for Kezar Life Sciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Equal Talent Investments Ltd 10% Owner | 2020-06-15 16:10:56 | 6,254,545 0 | 6,254,545 | Form 4 |
| Fowler John Franklin CEO | 2023-07-26 16:59:47 | 2,655,000 0 | 2,655,000 | Form 4 |
| Morningside Venture Investments Ltd 10% Owner | 2023-08-17 19:08:14 | 1,947,993 0 | 1,947,993 | Form 4 |
| Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Stampacchia Otello Lim Richard J. Paster Anne-Mari Former 10% Owner | 2018-06-25 19:07:20 | 693,272 693,272 | 1,386,544 | Form 4 |
| Henig Noreen Chief Medical Officer | 2023-07-26 17:02:56 | 980,000 0 | 980,000 | Form 4 |
| Kirk Christopher J. CEO | 2023-11-09 16:25:13 | 875,000 0 | 875,000 | Form 4 |
| BAY CITY CAPITAL LLC 10% Owner | 2018-06-28 18:22:40 | 0 622,229 | 622,229 | Form 4 |
| Onyx Therapeutics Inc. AMGEN INC 10% Owner | 2020-02-07 19:43:03 | 504,438 0 | 504,438 | Form 13G |
| Chiesi Ventures Inc. Chiesi Ventures LP Chiesi Giacomo 10% Owner | 2018-06-26 16:54:42 | 0 314,819 | 314,819 | Form 4 |
| Belsky Marc Chief Financial Officer | 2024-01-09 16:57:01 | 295,000 0 | 295,000 | Form 4 |
| Mordwinkin Nicholas Michael Chief Business Officer | 2024-01-09 16:56:20 | 275,000 0 | 275,000 | Form 4 |
| Aberdare Management Company LLC 10% Owner | 2018-06-27 16:45:50 | 136,643 0 | 136,643 | Form 4 |
| STEYER THOMAS F Former 10% owner | 2018-07-05 21:28:20 | 0 125,927 | 125,927 | Form 4 |
| Goel Niti Chief Medical Officer | 2019-01-08 17:10:26 | 75,000 0 | 75,000 | Form 4 |
| Kauffman Michael Director | 2024-06-21 16:20:14 | 50,000 0 | 50,000 | Form 4 |
| BERGER FRANKLIN M Director | 2024-06-21 16:20:14 | 50,000 0 | 50,000 | Form 4 |
| Klearman Micki Director | 2024-06-21 16:20:15 | 50,000 0 | 50,000 | Form 4 |
| COOPER GRAHAM K Director | 2024-06-21 16:20:16 | 50,000 0 | 50,000 | Form 4 |
| Wallace Courtney Director | 2024-06-21 16:20:17 | 50,000 0 | 50,000 | Form 4 |
| Garner Elizabeth Director | 2024-06-21 16:20:17 | 50,000 0 | 50,000 | Form 4 |
| Schiller Mark C. Chief Legal Officer | 2024-07-26 17:41:02 | 33,007 0 | 33,007 | Form 4 |
| Sommadossi Jean-Pierre Director | 2021-06-30 18:49:34 | 26,000 0 | 26,000 | Form 4 |
| Dinges Jason Director | 2021-06-30 18:46:47 | 26,000 0 | 26,000 | Form 4 |
| PAPPAS ARTHUR M A.M. Pappas Life Science Ventures V LP PV V CEO Fund LP AMP&A Management V LLC PAPPAS CAPITAL LLC 10% Owner | 2018-06-26 16:54:02 | 0 23,894 | 23,894 | Form 4 |
| Economides Vassiliki SVP, Strategy & External Aff. | 2021-03-29 17:55:04 | 11,320 0 | 11,320 | Form 4 |
| Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner | 2020-02-14 16:04:03 | 0 0 | 0 | Form 13G |
| Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner | 2020-02-14 16:04:03 | 0 0 | 0 | Form 13G |